Dopamine D3 receptor antagonist effects on the motivational effects of ethanol.
Dopaminergic systems are thought to play important roles in the motivational effects of ethanol. In the present experiments, we examined the effects of U99194A, a putative dopamine D(3) receptor antagonist, on ethanol-induced conditioned place preference, locomotor stimulation, taste aversion, and self-administration. In two separate studies with the use of a place conditioning procedure, adult male Swiss-Webster mice received six pairings of a tactile stimulus with ethanol (1 or 3 g/kg, i.p.), U99194A (20 mg/kg, i.p.), or ethanol + U99194A. For determination of ethanol-stimulated activity, subjects received U99194A at a dose of 0, 10, 20, or 30 mg/kg 15 min before ethanol at 0, 1, or 2 g/kg immediately before a 30-min locomotor activity test. In a taste conditioning procedure, subjects received five 1-h access periods to 0.2 M NaCl. After the first four access periods, subjects received ethanol at 0, 2, or 4 g/kg and U99194A at 0, 10, or 20 mg/kg. In an oral self-administration procedure, male C57BL/6J mice received U99194A at 0, 10, or 20 mg/kg, followed by 30-min access to 10% (wt./vol.) sucrose or 10% (vol./vol.) ethanol in 10% sucrose. The acquisition of ethanol-induced conditioned place preference was enhanced by U99194A. However, U99194A did not produce significant preference alone. U99194A did not alter locomotor stimulation produced by an injection of ethanol at 2 g/kg. U99194A also did not alter the acquisition of ethanol-induced conditioned taste aversion and did not change oral ethanol self-administration. These results support the suggestion that dopamine D(3) receptors have specific involvement in ethanol reward, as measured by place conditioning, but are not important for ethanol-stimulated activity, ethanol taste aversion, or ethanol intake.
Boyce
Janel M
JM
Department of Behavioral Neuroscience, L470, Portland Alcohol Research Center, Oregon Health & Science University, Portland, OR 97201-3098, USA. boycej@ohsu.edu
Risinger
Fred O
FO
D000818:Animals; D003213:Conditioning, Psychological / Q000187:drug effects / Q000502:physiology; D018492:Dopamine Antagonists / Q000494:pharmacology*; D065127:Dopamine D2 Receptor Antagonists; D004305:Dose-Response Relationship, Drug; D000431:Ethanol / Q000494:pharmacology*; D007189:Indans / Q000494:pharmacology; D008297:Male; D051379:Mice; D009042:Motivation; D009043:Motor Activity; D050637:Receptors, Dopamine D3
D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists; C493594:Drd3 protein, mouse; D007189:Indans; D050637:Receptors, Dopamine D3; C086335:(5,6-dimethoxyindan-2-yl)dipropylamine; D000431:Ethanol